SG
SGYP

Societe Generale’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Societe Generale’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$4.73M Buy
+1,244,557
New +$4.22M 0.03% 414

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Societe Generale's SGYP Position: Q2 2016 in Review

Societe Generale opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2016: 1,244,557 shares worth $4.73M. The stake represents 0.03% of the portfolio and ranks #414 among its holdings.

134 funds tracked by Wall St. Rank hold SGYP as of Q2 2016.

  • Societe Generale held 1,244,557 shares of Synergy Pharmaceuticals, Inc Common Stock worth $4.73M as of Q2 2016.
  • Synergy Pharmaceuticals, Inc Common Stock was a new Societe Generale position in Q2 2016.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.03% of Societe Generale's portfolio in Q2 2016, its #414 holding.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.